[pharmaceutical network industry trends] recently, the problem of employee placement after the merger of Pfizer and mylan has attracted wide attention in the industry
Former FDA director Scott Gottlieb joins Pfizer's board
Time of Update: 2019-06-28
After Thursday's close, Pfizer said that Scott Gottlieb, former FDA director, joined the company's board of directors.
Forbes' latest top 2000: Pfizer still tops the list of seven Chinese pharmaceutical companies
Time of Update: 2019-05-17
Among them, Sinopharm group, China Resources pharmaceutical and Shanghai Pharmaceutical are the top three circulation giants in the list, followed by Hengrui, Kangmei, Yunnan Baiyao, China biopharmaceutical, Shiyao group and other once "100 billion market value companies".
[exclusive] brief analysis of bidding dynamics in June 2018 (Pfizer 20 varieties applied for price reduction in Hubei, with a decrease of 3.4% - 10.2
Time of Update: 2018-07-06
Gansu also issued a notice on adjusting the bid price of some drugs.
Congratulate! Pfizer meningococcal vaccine is recognized as breakthrough therapy again
Time of Update: 2018-04-24
Source: Wuxi apptec, April 24, 2017, Pfizer announced today that its meningococcal B vaccine, trumenba, has been recognized by the US FDA as a breakthrough therapy for active
Baijian acquires Pfizer, the world's first schizophrenic cognitive disorder drug
Time of Update: 2018-03-13
Source: on March 12, 2018, Sina Pharma announced a purchase agreement with Pfizer on pf-04958242, a global first quasi clinical phase 2B AMPA receptor synergist for the treatment of schizophrenia related cognitive impairment (CIAS).
326 kinds of drugs are on the list of international giants such as Pfizer and Roche
Time of Update: 2017-01-04
The municipal (prefecture) health and family planning administrative department shall be responsible for summarizing the list of key monitoring drugs of medical institutions above the second level in its jurisdiction and timely releasing it to the public.
Pfizer, together with Parker, develops new drugs and opens a new mode of cooperation with Chinese Enterprises
Time of Update: 2016-12-14
According to the agreement, Pfizer will authorize Paige to develop a leading-edge glucokinase agonist (GKA) drug in the field of diabetes suitable for Chinese patients, bringing good news to more than 114 million diabetics in China.
Pfizer and the American Cancer Institute (NCI) have reached a cooperation to develop three tumor immunotherapies to treat multiple tumors
Time of Update: 2016-11-17
Source: Biovalley 2016-11-17 US pharmaceutical giant Pfizer recently announced a cooperative research and development agreement (crada) with the National Cancer Institute (NCI
Pfizer sells hospita infusion department and New York headquarters
Time of Update: 2016-10-09
In addition, Pfizer confirmed in an interview with the Wall Street Journal that it plans to sell its New York headquarters by the end of 2017, and the company will move to another office building in Manhattan as a whole.
Pfizer's US $250 million cooperation with oncoimmune to develop CTLA4 McAb onc-392
Time of Update: 2016-09-22
Source: Biovalley 2016-9-22 recently, US pharmaceutical giant Pfizer announced that it would reach an R & D agreement with oncoimmune, a Maryland based biopharmaceutical company
Package sale! AstraZeneca sells $1.6 billion in antibiotic business to Pfizer
Time of Update: 2016-08-29
Atm-avi is a compound injection of aztreonam combined with avibatan, which is currently in phase II clinical trial for the treatment of multi drug resistant gram negative bacterial infection.
Pfizer first but not the fastest growing multinational pharmaceutical company in China
Time of Update: 2016-08-25
In the first half of 2016, the total sales volume of 22 multinational pharmaceutical enterprises in China was 64.768 billion yuan, with an average growth rate of 9.74%.